Prescription drug pricing.
If passed, AB 1460 would contribute to a more equitable pricing structure for prescription drugs by creating protections for covered entities (such as hospitals and clinics) that provide medications to patients covered under Medi-Cal. By prohibiting discriminative actions from drug manufacturers, the bill is poised to improve the affordability of outpatient drugs, especially for low-income populations who rely heavily on this program.
Assembly Bill No. 1460, introduced by Assembly Member Rogers, aims to amend the Health and Safety Code by adding Section 127472, which relates to prescription drug pricing. It specifically addresses issues surrounding the pricing of outpatient drugs that are governed under federal pricing regulations. The bill seeks to ensure that prescription drug manufacturers do not engage in discriminatory practices which could limit the ability of covered entities to purchase these drugs at fair prices, thereby enhancing access for eligible patients utilizing specified pharmacies.
There may be contention around this bill, particularly from pharmaceutical manufacturers who might argue that the restrictions could impact their pricing strategies and profit margins. However, supporters of AB 1460 likely advocate for the necessity of these provisions to combat pricing inequalities and ensure that all patients have access to necessary medications without undue barriers. This could lead to discussions in legislative sessions about the balance between pharmaceutical profit and public health equity.